Status: Recruiting
A Clinical Study of GeminiOne TEER System for the Treatment of Severe, Symptomatic MR.
To confirm the effectiveness and safety of the GeminiOne Transcatheter Mitral Valve Repair System for the treatment of severe, symptomatic mitral regurgitation.
Participants needed: 15
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Sierra Valve LLCUpdated: Apr 24, 2026Locations: 1
Eligibility criteria
Age 18 years or older(≥ 18 years) [+4]
History of heart transplantation, prior mitral valve replacement surgery, or tra... [+10]